Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)

China flag China · Delayed Price · Currency is CNY
29.22
+0.18 (0.62%)
Apr 29, 2026, 3:00 PM CST
-23.48%
Market Cap 9.18B
Revenue (ttm) 1.94B
Net Income (ttm) 327.00M
Shares Out 316.05M
EPS (ttm) 1.04
PE Ratio 27.92
Forward PE 14.31
Dividend 0.64 (2.21%)
Ex-Dividend Date n/a
Volume 1,348,509
Average Volume 2,645,290
Open 29.00
Previous Close 29.04
Day's Range 28.87 - 29.29
52-Week Range 28.18 - 50.86
Beta 0.39
RSI 40.93
Earnings Date Apr 30, 2026

About SHA:688076

Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China. The company offers Peptide CDMO Services,GMP oligo, full-time equivalent, discovery, generic APIs, and formulation services. It is also involved in professional technical services. The company was founded in 2009 and is headquartered in Hangzhou, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 2,247
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688076
Full Company Profile

Financial Performance

In 2025, SHA:688076's revenue was 1.94 billion, an increase of 19.57% compared to the previous year's 1.62 billion. Earnings were 327.00 million, a decrease of -19.14%.

Financial Statements

News

There is no news available yet.